By Rebecca Torrence
Wellinks has raised $25 million in series C funding for its virtual platform for treating chronic obstructive pulmonary disease (COPD), the company announced Wednesday.
The company links medical devices like pulse oximeters with a mobile app, which can connect patients with health coaches and rehabilitation therapy tools. It’s the first of its kind, the only company to deliver an integrated virtual solution for treating COPD, according to Alex Waldron, Wellinks CEO.
“No one has created a fully integrated solution that brings all of these things together, and that’s where the power is,” he told Fierce Healthcare. “Having a piece of it is good, but you’re not going to approach everything the patient needs until you put it all in one system in a way that’s convenient for them, the providers and the payers.”